APA (7th ed.) Citation

R, S., DM, R., M, Y., AW, B., MS, B., & TJ, H. (2026). Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapy. Therapeutic advances in medical oncology, 18, 17588359251412729. https://doi.org/10.1177/17588359251412729

Chicago Style (17th ed.) Citation

R, Stoff, Routman DM, Yalon M, Bogan AW, Block MS, and Hieken TJ. "Biomarker Analysis of Circulating Tumor DNA in Clinical Stage III Melanoma Patients Treated with Neoadjuvant Immunotherapy Combined with Targeted Therapy." Therapeutic Advances in Medical Oncology 18 (2026): 17588359251412729. https://doi.org/10.1177/17588359251412729.

MLA (9th ed.) Citation

R, Stoff, et al. "Biomarker Analysis of Circulating Tumor DNA in Clinical Stage III Melanoma Patients Treated with Neoadjuvant Immunotherapy Combined with Targeted Therapy." Therapeutic Advances in Medical Oncology, vol. 18, 2026, p. 17588359251412729, https://doi.org/10.1177/17588359251412729.